Literature DB >> 11585423

Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix.

P H Wang1, Y F Li, C M Juang, Y R Lee, H T Chao, Y C Tsai, C C Yuan.   

Abstract

OBJECTIVE: Increased sialylation has been reported in various kinds of cancers, but to date, sialylation of cervical carcinoma has never been evaluated. This study of the changes in messenger ribonucleic acid (mRNA) expression of the four sialyltransferases (ST3Gal I, ST3Gal III, ST3Gal IV, and ST6Gal I) in a normal cervix and that with FIGO stage IB1 squamous cell carcinoma was undertaken to assess the extent of sialylation associated with establishment of the carcinoma.
METHODS: Alterations in ST mRNA expression in FIGO IB1 cervical cancer (n = 30) and normal cervixes (n = 30) were examined by semiquantitative reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS: ST6Gal I expression was enhanced in squamous cell carcinoma of the cervix (P = 0.026, Mann-Whitney U test), but mRNA expression from the other three STs (ST3Gal I, ST3Gal III, and ST3Gal IV) was significantly down-expressed in squamous cell carcinoma of the cervix compared to the normal cervix (P = 0.003, P < 0.001, and P = 0.001, respectively). High ST6Gal I expression was associated with more invasive properties of cervical cancer, such as deep stromal invasion, lymph or vascular space involvement, and poor differentiation (P = 0.010, P < 0.001, P < 0.001, respectively).
CONCLUSIONS: A combination of enhanced ST6Gal I mRNA expression and decreased mRNA expression from ST3Gal I, ST3Gal III, and ST3Gal IV might be important in cervical cancer. Future studies will investigate whether RT-PCR detection of the expression of these enzymes can be helpful for prognostic purposes. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585423     DOI: 10.1006/gyno.2001.6358

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  22 in total

Review 1.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

2.  Altered expression of sialylated glycoproteins in breast cancer using hydrazide chemistry and mass spectrometry.

Authors:  Yuan Tian; Francisco J Esteva; Jin Song; Hui Zhang
Journal:  Mol Cell Proteomics       Date:  2012-02-07       Impact factor: 5.911

3.  alpha2,6-hyposialylation of c-Met abolishes cell motility of ST6Gal-I-knockdown HCT116 cells.

Authors:  Jin Qian; Cai-Hua Zhu; Shuai Tang; Ai-Jun Shen; Jing Ai; Jing Li; Mei-Yu Geng; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2009-06-01       Impact factor: 6.150

Review 4.  Glycosylation: a hallmark of cancer?

Authors:  Bhairavi N Vajaria; Prabhudas S Patel
Journal:  Glycoconj J       Date:  2016-12-14       Impact factor: 2.916

5.  Transmembrane mucins as novel therapeutic targets.

Authors:  Pamela E Constantinou; Brian P Danysh; Neeraja Dharmaraj; Daniel D Carson
Journal:  Expert Rev Endocrinol Metab       Date:  2011-11

6.  Alpha-2, 3-sialyltransferases regulate the multidrug resistance of chronic myeloid leukemia through miR-4701-5p targeting ST3GAL1.

Authors:  Yan Li; Shihua Luo; Weijie Dong; Xiaobo Song; Huimin Zhou; Lifen Zhao; Li Jia
Journal:  Lab Invest       Date:  2016-04-18       Impact factor: 5.662

7.  Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma.

Authors:  Terence C W Poon; Clarissa H S Chiu; Paul B S Lai; Tony S K Mok; Benny Zee; Anthony T C Chan; Joseph J Y Sung; Philip J Johnson
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

8.  Increased expression of sialic acid in cervical biopsies with squamous intraepithelial lesions.

Authors:  Dolores López-Morales; Julio Reyes-Leyva; Gerardo Santos-López; Edgar Zenteno; Verónica Vallejo-Ruiz
Journal:  Diagn Pathol       Date:  2010-11-22       Impact factor: 2.644

9.  Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms.

Authors:  Faheem M Shaikh; Eric C Seales; William C Clem; Kristin M Hennessy; Ya Zhuo; Susan L Bellis
Journal:  Exp Cell Res       Date:  2008-07-30       Impact factor: 3.905

10.  Differential N-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous system.

Authors:  Uros Kuzmanov; Nianxin Jiang; Christopher R Smith; Antoninus Soosaipillai; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2008-12-16       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.